Chronic Total Occlusion (CTO) Device Market Size, Share & Trends Analysis | Global | 2025-2032 | MedCore | Includes: Re-entry and Recanalization Devices

Year: 2026
Scope: 10 Years
Region: Global
Published Date: 12/05/2025
Type: MedCore

Product Description

The global chronic total occlusion (CTO) device market was valued at $214 million in 2025. This is expected to increase over the forecast period at a CAGR of 2.7% to reach $257 million by 2032.

The full report on the global CTO device market includes re-entry devices and recanalization devices.

The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

Data Types Included

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2032, and Historical Data to 2022
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

Chronic Total Occlusion (CTO) Device Market Trends

An emerging trend in the CTO device market is the increasing emphasis on advanced guidewire and microcatheter technologies, enabling enhanced crossing and navigation through challenging lesions. These innovations are facilitating greater procedural success rates and reduced patient risk, as interventional cardiologists seek more effective tools to address complex chronic total occlusion cases.

Chronic Total Occlusion (CTO) Device Market Share Insights

Medtronic’s involvement in the CTO device sector has undergone significant transformation over the last 5 years. Before August 2013, Medtronic was engaged in marketing the Pioneer Plus® re-entry catheter range. However, this product line was acquired by Volcano Corp. in August 2013. In January 2015, Medtronic’s landscape further evolved with the acquisition of Covidien. Presently, Medtronic is actively promoting the Enteer™ Re-entry System and the Viance™ Crossing Catheter in the CTO device market.
Cardinal Health The company currently markets the Outback® re-entry and Frontrunner® recanalization devices. Cardinal Health benefits by bundling its CTO products with sales of its other endovascular products. The company dominated the CTO market in Europe, with approximately half of the total market share.
Becton Dickinson acquired FlowCardia, a manufacturer of the Crosser® device. The FDA had granted approval to the Crosser® in 2007, and, in 2011, it also received an indication for atherectomy procedures, resulting in a pricing modification. Physicians do not receive reimbursements for utilizing CTO devices, making the acquisition of the atherectomy indication crucial for Becton Dickinson to distinguish its product in a competitive market.

Chronic Total Occlusion (CTO) Device Market Segmentation Summary

Re-Entry Device Market
Recanalization Device Market

Research Scope Summary

Report Attribute	Details
Regions	North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year	2025
Forecast	2026-2032
Historical Data	2022-2024
Quantitative Coverage	Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage	Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources	Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report

List Of Figures

List Of Charts

Research Methodology

Step 1: Project Initiation & Team Selection

Step 2: Prepare Data Systems And Perform Secondary Research

Step 3: Preparation For Interviews & Questionnaire Design

Step 4: Performing Primary Research

Step 5: Research Analysis: Establishing Baseline Estimates

Step 6: Market Forecast And Analysis

Step 7: Identify Strategic Opportunities

Step 8: Final Review And Market Release

Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Chronic Total Occlusion Device Market

9.1 Executive Summary

9.1.1 Global Chronic Total Occlusion Device Market Overview

9.1.2 Competitive Analysis

9.1.3 Procedures Included

9.1.4 Markets Included

9.1.5 Regions Included

9.2 Introduction

9.3 Procedure Numbers

9.3.1 Total Cto Procedures

9.3.2 Re-Entry Procedures

9.3.3 Recanalization Procedures

9.4 Market Overview

9.4.1 By Segment

9.4.2 By Region

9.5 Market Analysis And Forecast

9.5.1 Total Chronic Total Occlusion Device Market

9.5.2 Re-Entry Device Market

9.5.3 Recanalization Device Market

9.6 Drivers And Limiters

9.6.1 Market Drivers

9.6.2 Market Limiters

9.7 Competitive Market Share Analysis

Abbreviations

Companies Included

· Aachen Resonance GmbH	·LeMaitre Vascular
· Abbott Vascular	·Maquet
· Acandis GmbH	·Medtronic
· ACIST Medical	·Merit Medical Systems
·Acrostak	·MiCroPort
·Affluent Medical	·Natec Medical Ltd.
·AngioDynamics	·Nordion
·Argon Medical	·Optimed
·Asahi Intecc	·Oscor Inc.
·Avimedica	·Penumbra
·Avinger	·Philips
·B. Braun	·plus Medica
·Becton Dickinson	·Ra Medical
·Biosensors International Group Ltd.	·Rafael Medical Technologies
·BIOTRONIK	·Reva Medical
·Biovic	·Rex Medical
·Blockade Medical	·Scitech Medical
·Boston Scientific	·Shockwave Medical
·Cardinal Health	·Sirtex
·Cardionovum GmbH	·SoundBite Medical Solutions
·Cardiovascular Systems Inc.	·Straub Medical
·Cardiva	·Teleflex
·Celenova Biosciences Inc.	·Terumo
·Concept Medical	·Theragenics
·Contego Medical	·Vascular Solutions
·Control Medical Technology	·Vascular Flow Technologies
·Cook Medical	·Vasorum
·Endospan	·Varian Medical Systems
·Eurocor	·Vivasure Medical
·Infraredx Inc.	·W.L. Gore
·InSeal Medical	·Walk Vascular
·Jotec

Chart List

Chart 9-1: CTO Device Market, Global, 2025 & 2032

Chart 9-2: CTO Procedures, Global, 2025

Chart 9-3: CTO Procedures by Region, Global, 2022 – 2032

Chart 9-4: CTO Device Market by Segment, Global, 2022 – 2032

Chart 9-5: CTO Device Market by Region, Global, 2022 – 2032

Chart 9-6: Leading Competitors, CTO Device Market, Global, 2025

Figure List

Figure 9-1: CTO Device Procedures Covered

Figure 9-2: CTO Device Markets Covered

Figure 9-3: CTO Device Regions Covered, Global (1 of 2)

Figure 9-4: CTO Device Regions Covered, Global (2 of 2)

Figure 9-5: CTO Procedures by Segment, Global, 2022 – 2032

Figure 9-6: CTO Procedures by Region, Global, 2022 – 2032

Figure 9-7: CTO Procedures by Country, North America, 2022 – 2032

Figure 9-8: CTO Procedures by Country, Latin America, 2022 – 2032 (1 of 2)

Figure 9-9: CTO Procedures by Country, Latin America, 2022 – 2032 (2 of 2)

Figure 9-10: CTO Procedures by Country, Western Europe, 2022 – 2032

Figure 9-11: CTO Procedures by Country, Central & Eastern Europe, 2022 – 2032 (1 of 2)

Figure 9-12: CTO Procedures by Country, Central & Eastern Europe, 2022 – 2032 (2 of 2)

Figure 9-13: CTO Procedures by Country, Middle East, 2022 – 2032

Figure 9-14: CTO Procedures by Country, Asia-Pacific, 2022 – 2032 (1 of 3)

Figure 9-15: CTO Procedures by Country, Asia-Pacific, 2022 – 2032 (2 of 3)

Figure 9-16: CTO Procedures by Country, Asia-Pacific, 2022 – 2032 (3 of 3)

Figure 9-17: CTO Procedures by Country, Africa, 2022 – 2032

Figure 9-18: Re-Entry Procedures by Region, Global, 2022 – 2032

Figure 9-19: Re-Entry Procedures by Country, North America, 2022 – 2032

Figure 9-20: Re-Entry Procedures by Country, Latin America, 2022 – 2032 (1 of 2)

Figure 9-21: Re-Entry Procedures by Country, Latin America, 2022 – 2032 (2 of 2)

Figure 9-22: Re-Entry Procedures by Country, Western Europe, 2022 – 2032

Figure 9-23: Re-Entry Procedures by Country, Central & Eastern Europe, 2022 – 2032 (1 of 2)

Figure 9-24: Re-Entry Procedures by Country, Central & Eastern Europe, 2022 – 2032 (2 of 2)

Figure 9-25: Re-Entry Procedures by Country, Middle East, 2022 – 2032

Figure 9-26: Re-Entry Procedures by Country, Asia-Pacific, 2022 – 2032 (1 of 3)

Figure 9-27: Re-Entry Procedures by Country, Asia-Pacific, 2022 – 2032 (2 of 3)

Figure 9-28: Re-Entry Procedures by Country, Asia-Pacific, 2022 – 2032 (3 of 3)

Figure 9-29: Re-Entry Procedures by Country, Africa, 2022 – 2032

Figure 9-30: Recanalization Procedures by Region, Global, 2022 – 2032

Figure 9-31: Recanalization Procedures by Country, North America, 2022 – 2032

Figure 9-32: Recanalization Procedures by Country, Latin America, 2022 – 2032 (1 of 2)

Figure 9-33: Recanalization Procedures by Country, Latin America, 2022 – 2032 (2 of 2)

Figure 9-34: Recanalization Procedures by Country, Western Europe, 2022 – 2032

Figure 9-35: Recanalization Procedures by Country, Central & Eastern Europe, 2022 – 2032 (1 of 2)

Figure 9-36: Recanalization Procedures by Country, Central & Eastern Europe, 2022 – 2032 (2 of 2)

Figure 9-37: Recanalization Procedures by Country, Middle East, 2022 – 2032

Figure 9-38: Recanalization Procedures by Country, Asia-Pacific, 2022 – 2032 (1 of 3)

Figure 9-39: Recanalization Procedures by Country, Asia-Pacific, 2022 – 2032 (2 of 3)

Figure 9-40: Recanalization Procedures by Country, Asia-Pacific, 2022 – 2032 (3 of 3)

Figure 9-41: Recanalization Procedures by Country, Africa, 2022 – 2032

Figure 9-42: CTO Device Market by Segment, Global, 2022 – 2032 (US$M)

Figure 9-43: CTO Device Market by Region, Global, 2022 – 2032 (US$M)

Figure 9-44: Total CTO Device Market, Global, 2022 – 2032

Figure 9-45: Units Sold by Region, CTO Device Market, Global, 2022 – 2032

Figure 9-46: Average Selling Price by Region, CTO Device Market, Global, 2022 – 2032 (US$)

Figure 9-47: Market Value by Region, CTO Device Market, Global, 2022 – 2032 (US$M)

Figure 9-48: Re-Entry Device Market, Global, 2022 – 2032

Figure 9-49: Units Sold by Region, Re-Entry Device Market, Global, 2022 – 2032

Figure 9-50: Average Selling Price by Region, Re-Entry Device Market, Global, 2022 – 2032 (US$)

Figure 9-51: Market Value by Region, Re-Entry Device Market, Global, 2022 – 2032 (US$M)

Figure 9-52: Recanalization Device Market, Global, 2022 – 2032

Figure 9-53: Units Sold by Region, Recanalization Device Market, Global, 2022 – 2032

Figure 9-54: Average Selling Price by Region, Recanalization Device Market, Global, 2022 – 2032 (US$)

Figure 9-55: Market Value by Region, Recanalization Device Market, Global, 2022 – 2032 (US$M)

Figure 9-56: Leading Competitors, CTO Device Market, Global, 2025

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

Original primary research that consists of the most up-to-date market data
Strong foundation of quantitative and qualitative research
Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Report Options

Report Summary

FREE

Select License Type

Overall, the global chronic total occlusion (CTO) device market was valued at $225 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.2% to reach $262 million.